Navigation Links
Early origins of maize in Mexico
Date:6/26/2008

The paleobotanist Dolores Piperno and her colleagues have established a number of criteria for distinguishing the starch grains of different grasses and found that those of maize and teosinte could be reliably separated on the basis of size and other morphological characters.

Maize also has a rich genetic history, which has resulted in thousands of varieties or landraces adapted to different environmental conditions. Maize scientists and geneticists have used this information to track the evolution and dispersal of maize varieties as well as to reconstruct the history of maize domestication. For example, the locus teosinte glume architecture 1 (tga1), is important in determining phytolith formation and morphology and, along with other "domestication genes" can be used to write the history of maize domestication and use by humans.

All of these methods are being used by paleobotanists, plant scientists, and archeologists like Jones and his colleagues, to reconstruct the rich history of maize domestication and evolution. Many of the ancient varieties were adaptations to different environmental conditions such as different soils, temperature, altitude, and drought. Preservation of these varieties and knowledge of their genetic and adaptive histories are of paramount importance as farmers around the world cope with changes in soil, temperature, and water availability and struggle to maintain a food supply for growing populations.


'/>"/>

Contact: Dr. John Jones
jonesjg@wsu.edu
509-335-3348
American Society of Plant Biologists
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. 60 second test could help early diagnosis of common brain diseases
2. Restless legs syndrome affects nearly 2 percent of US/UK children
3. Bleeding, not inflammation, is major cause of early lung infection death
4. Pig study sheds new light on the colonisation of Europe by early farmers
5. Color contrast is seen by the brain early doors
6. Extra gene copies were enough to make early humans mouths water
7. Was ability to run early mans Achilles heel?
8. New technique can be breakthrough for early cancer diagnosis
9. Yam bean a nearly forgotten crop
10. NIH awards nearly $23M to University of Chicago for translational research
11. Yam bean a nearly forgotten crop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2015)... 9, 2015  Lintec of America recently announced an ... nanotube (CNT) macrostructures, including sheets, yarns and ribbons, developed ... Leveraging the vast industrial resources of the global ... , Lintec of America is forming the Nano-Science and ... , focusing on scaling up the manufacturing and commercialization ...
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... corporate website ( http://www.nxt-id.com/ ) as part of its ... wallet. The Company launched its new consumer website for ... Pereira , CEO of NXT-ID said, "Our new corporate ...
Breaking Biology News(10 mins):Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marken Launches New Patient-Centric Campaign 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... 1, 2010 2009 estimates projected that in the United ... diagnosed and 14,600 women would die of the disease. ... onset and a relatively low 5-year survival rate of about ... published in the March 2010 issue of the Journal ...
... The next treatment for cancer might come from fish says ... edition of the FASEB Journal ( http://www.fasebj.org ). ... "docosahexaenoic acid" or "DHA," and its derivatives in the body ... treatments for a wide range of cancers, including neuroblastoma, medulloblastoma, ...
... CITY, March 1, 2010 Like silkworm moths, butterflies and ... instead on dry land. Now, University of Utah researchers have ... how that may make it valuable as an adhesive tape ... western fly fishermen as ,rock rollers, may be useful ...
Cached Biology News:Dietary factors influence ovarian cancer survival rates 2Glue, fly, glue 2Glue, fly, glue 3Glue, fly, glue 4Glue, fly, glue 5
(Date:3/5/2015)... March 5, 2015  In response to the incorrect ... Miami, FL on February 12, 2015. Impeto ... strong financial health and their SUDOSCAN® devices have been ... indicated. Furthermore, Impeto prefers to have the courts decide this ... more than 40 articles written by Key Opinion Leaders, ...
(Date:3/4/2015)... In an article published and posted online ... Security review the clinical aspects of diseases caused by ... The article, "Clinical Management of Potential Bioterrorism-Related Conditions," was ... the New England Journal of Medicine . ... and Tom Inglesby—review the clinical management of conditions resulting ...
(Date:3/4/2015)... , Mar. 04, 2015 Research and Markets ... addition of the "Global Biologics and Biosimilars ... , The Global Biologics and ... in-depth study on the current state of the ... provides a basic overview of the industry including ...
(Date:3/4/2015)... Pa. , March 4, 2015 /PRNewswire/ ... services and technology provider, today announced that ... 10 countries convened at its annual European ... to discuss the use of ... challenges. BioClinica,s eClinical technologies include: the Microsoft ...
Breaking Biology Technology:Impeto Medical Responds to Published Allegations by LD Technology LLC ("LD") 2Latest Clinical Information On Bioterrorism Threats 2Global Biologics and Biosimilars Industry Report 2015-2020 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3
... Delcath Systems, Inc. (Nasdaq: DCTH ) today announced ... as a director of the Company, effective December 2, 2008. ... Delcath board is a result of additional commitments to new leadership ... http://www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO ) , , Dr. Harold ...
... QUEBEC CITY, Dec. 4 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. ... biopharmaceutical company focused on endocrine therapy and oncology, today ... will take part in a panel discussion titled, "Replacing ... upcoming RBC Capital Markets 2008 Healthcare Conference on Wednesday, ...
... (NASDAQ:LIFE), a provider of innovative life science research ... for next-generation genomic analysis, the SOLiD™ System, has ... Year for 2008 by The Scientist, a leading ... In making the announcement of the first-ever Life ...
Cached Biology Technology:Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors 2 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 2 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 3 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 4 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 5